FDA Inspections

From knowledgebase
Revision as of 07:19, 25 August 2020 by Dirkjan (talk | contribs) (Created page with "To understand FDA Inspections the following concepts & definitions are important during inspections: * A Bottum-up inspection was the FDA standard ins...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

To understand FDA Inspections the following concepts & definitions are important during inspections:

  • A Bottum-up inspection was the FDA standard inspection prior to 1998.
  • Comprehensive inspection is an inspection on all elements of a firms quality system.
  • Directed inspection is an inspection performed on specific elements of a firm's quality system.
  • Establishment Inspection Report, is a report completed by the FDA after an inspection.
  • Form FDA 482, is a notice of inspection.
  • Form FDA 483, contains the inspectional observations.
  • Quality System Inspection Technique (QSIT) is the FDA's current inspection technique.
  • A Table-Top Inspection is an inspection strategy of reviewing a firm's written procedures and records.
  • A Top-Down Inspection is the FDA's latest inspection strategy in which inspectors are taught to evaluate the quality system and sampling quality system records
  • Track I Inspection is a limitted inspection of the quality system conduced every two years
  • Track II Inspection is a complete audit every four years
  • Situation I conditions are those conditions that provide evidence that there are significant errors in the manufacturers production process leading to defective devices.
  • Situation II conditions are those conditions that are not meeting the Situation I conditions.
  • A Warning Letter is an administrative action typically issued to firms with Situation I conditions.

Inspection frequency

The FDA does not need a warrant to inspect any device manufacturer. Refusal to permit the inspection is a violation of The Act.

The following situations enter into the inspection assesment:

  1. Manufacturers whose last inspection was violative and who provided little or no compelling evidence of corrective measures
  2. Manufacures who received 510(k) clearance for a high-risk device within the past 12 months and who have not been inspected within the previous 2 years.
  3. Manufacturers of class II and class III devices who have never been inspected
  4. Manufacturers who have newly registered
  5. Manufacturers with a recently cleared 510(k)